Eaton Vance Management increased its stake in shares of Xylem Inc. (NYSE:XYL) by 179.1% during the second quarter, Holdings Channel reports. The institutional investor owned 14,624 shares of the company’s stock after buying an additional 9,384 shares during the period. Eaton Vance Management’s holdings in Xylem were worth $653,000 as of its most recent filing with the SEC.
Other institutional investors also recently added to or reduced their stakes in the company. Glenmede Trust Co. NA increased its position in Xylem by 9.4% in the second quarter. Glenmede Trust Co. NA now owns 2,908 shares of the company’s stock valued at $129,000 after buying an additional 250 shares during the period. Invictus RG acquired a new position in Xylem during the first quarter valued at approximately $142,000. Evercore Wealth Management LLC increased its position in Xylem by 6.3% in the second quarter. Evercore Wealth Management LLC now owns 3,315 shares of the company’s stock valued at $148,000 after buying an additional 195 shares during the period. BlueMountain Capital Management LLC acquired a new position in Xylem during the first quarter valued at approximately $180,000. Finally, Lincoln Capital LLC acquired a new position in Xylem during the second quarter valued at approximately $200,000. Hedge funds and other institutional investors own 84.70% of the company’s stock.
Shares of Xylem Inc. (NYSE:XYL) traded down 0.08% on Thursday, reaching $52.17. 532,938 shares of the company were exchanged. Xylem Inc. has a 12-month low of $31.67 and a 12-month high of $52.68. The firm has a market capitalization of $9.35 billion, a PE ratio of 27.85 and a beta of 1.15. The stock’s 50-day moving average is $50.53 and its 200 day moving average is $45.53.
Xylem (NYSE:XYL) last posted its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. The business earned $932 million during the quarter, compared to analyst estimates of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The company’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.43 EPS. On average, analysts forecast that Xylem Inc. will post $2.04 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, September 21st. Shareholders of record on Wednesday, August 31st were issued a dividend of $0.1549 per share. This represents a $0.62 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date of this dividend was Monday, August 29th. Xylem’s payout ratio is presently 33.16%.
Several equities analysts recently commented on XYL shares. Royal Bank Of Canada upgraded shares of Xylem from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $37.00 to $42.00 in a research note on Wednesday, June 1st. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $52.00 price target (up from $46.00) on shares of Xylem in a research note on Monday, June 20th. Zacks Investment Research downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research note on Friday, July 15th. Barclays PLC upped their price target on shares of Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research note on Monday, July 18th. Finally, RBC Capital Markets set a $51.00 price target on shares of Xylem and gave the company a “buy” rating in a research note on Tuesday, August 16th. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Xylem has an average rating of “Hold” and a consensus target price of $45.00.
In other Xylem news, insider Tomas Brannemo sold 8,524 shares of Xylem stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $50.06, for a total transaction of $426,711.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Colin R. Sabol sold 27,473 shares of Xylem stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $50.91, for a total value of $1,398,650.43. Following the transaction, the insider now directly owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The disclosure for this sale can be found here. Company insiders own 0.77% of the company’s stock.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.